[Acute lymphoblastic leukemia. Study on 34 children (author's transl)]

Area of Science:

• Pediatric Oncology
• Hematology
• Clinical Research

Background:

• Leukemia-Lymphoma Association (L.L.A.) is a significant concern in pediatric oncology.
• Understanding the interplay between L.L.A. and other tumor types is crucial for comprehensive treatment.

Purpose of the Study:

• To analyze clinical presentation, cytochemistry, and evolution of L.L.A. in children aged 2-5 years.
• To compare treatment responses and survival outcomes in L.L.A. patients receiving different therapeutic approaches.
• To investigate the association between L.L.A. and other localized tumors in pediatric cases.

Main Methods:

• Retrospective analysis of 34 children diagnosed with L.L.A.
• Comparison with 37 pediatric patients presenting with diverse tumor types.
• Evaluation of clinical data, cytochemical markers, treatment protocols, and patient survival.

Main Results:

• Differential treatment responses observed in L.L.A. patient groups.
• Varied survival possibilities correlating with therapeutic strategies and tumor characteristics.
• Insights into the potential relationship between L.L.A. and other malignancies in children.

Conclusions:

• Therapeutic strategies significantly impact L.L.A. outcomes in pediatric patients.
• The association between L.L.A. and other tumors warrants further investigation for improved pediatric cancer care.